Overview

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection

Status:
Unknown status

Trial end date:
2018-11-01

Target enrollment:

Participant gender:

Summary

Pilot study to evaluate the impact of extremely early ART in the dynamics of viral reservoir, immune activation and inflammation in patients with HIV-1 infection of less than 20 days (Fiebig stages I-II) compared to patients with infection of 20-100 days (Fiebig stages III-V), to induce HIV functional cure.

Phase:

Phase 3

Details

Lead Sponsor:

David Garcia Cinca

Collaborator:

Fundacion Clinic per a la Recerca Biomédica

Treatments:

Anti-Retroviral Agents